Skip to content

Concentration-effect relationship of ultrasound-guided ropivacaine transverse abdominal plane combined with rectus sheath block for peritoneal dialysis catheterization in elderly patients with renal failure

Concentration-effect relationship of ultrasound-guided ropivacaine transverse abdominal plane combined with rectus sheath block for peritoneal dialysis catheterization in elderly patients with renal failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097711
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure

Interventions

0.2% ropivacaine groups:0.2% ropivacaine ultrasound-guided transversus abdominis plane combined with rectus abdominis sheath block
0.3% ropivacaine groups:0.3% ropivacaine ultrasound-guided transversus abdominis plane combined with rectus abdominis sheath block
0.4% ropivacaine groups:0.4% ropivacaine ultrasound-guided transversus abdominis plane combined with rectus abdominis sheath block
0.5% ropivacaine groups:0.5% ropivacaine ultrasound-guided transversus abdominis plane combined with rectus abdominis sheath block

Sponsors

Tianjin Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Patients with chronic renal failure who have indications for surgery should undergo elective abdominal catheterization surgery; 2. Gender is not limited, age is 65-74 years old, BMI is 18-28kg/m^2, ASA grade III or IV; 3. Patients give informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe coagulation dysfunction before surgery; 2. Those who have recently or long-term taken analgesic or psychiatric drugs; 3. Individuals allergic to lidocaine or ropivacaine; 4. Patients with skin infection or abdominal wall deformities at the puncture site; 5. Individuals with severe circulatory and respiratory system dysfunction; 6. Individuals with coexisting mental illnesses or cognitive impairments; 7. Overweight individuals (exceeding 20% of standard body mass); 8. Those who refuse to accept this anesthesia method will voluntarily withdraw from the study during the research process.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale Score;Mean arterial pressure;Heart rate;Evaluation of nerve block effect;Doctor satisfaction;Patient satisfaction;Operation duration;Surgical duration;Adjuvant medication;Add local anesthesia;Complication;

Secondary

MeasureTime frame
Adverse reactions;

Countries

China

Contacts

Public ContactYu Baochen

Tianjin Third Central Hospital

44919457@qq.com+86 159 2204 5889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026